These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21460033)

  • 21. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study.
    Jacobs MA; Barker PB; Bottomley PA; Bhujwalla Z; Bluemke DA
    J Magn Reson Imaging; 2004 Jan; 19(1):68-75. PubMed ID: 14696222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?
    Baltzer PA; Gussew A; Dietzel M; Rzanny R; Gajda M; Camara O; Reichenbach JR; Kaiser WA
    NMR Biomed; 2012 Jan; 25(1):67-74. PubMed ID: 21557368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
    Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
    Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
    Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: a proton MR spectroscopy and diffusion-tensor imaging study.
    Liu HS; Chou MC; Chung HW; Cho NY; Chiang SW; Wang CY; Kao HW; Huang GS; Chen CY
    Radiology; 2011 Aug; 260(2):531-40. PubMed ID: 21633053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T.
    Meisamy S; Bolan PJ; Baker EH; Pollema MG; Le CT; Kelcz F; Lechner MC; Luikens BA; Carlson RA; Brandt KR; Amrami KK; Nelson MT; Everson LI; Emory TH; Tuttle TM; Yee D; Garwood M
    Radiology; 2005 Aug; 236(2):465-75. PubMed ID: 16040903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial.
    Poellinger A; Persigehl T; Mahler M; Bahner M; Ponder SL; Diekmann F; Bremer C; Moesta T
    Invest Radiol; 2011 Nov; 46(11):697-704. PubMed ID: 21788905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
    Tozaki M; Fukuma E
    AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
    Scheenen TW; Heijmink SW; Roell SA; Hulsbergen-Van de Kaa CA; Knipscheer BC; Witjes JA; Barentsz JO; Heerschap A
    Radiology; 2007 Nov; 245(2):507-16. PubMed ID: 17848681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
    Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative and qualitative (23)Na MR imaging of the human kidneys at 3 T: before and after a water load.
    Haneder S; Konstandin S; Morelli JN; Nagel AM; Zoellner FG; Schad LR; Schoenberg SO; Michaely HJ
    Radiology; 2011 Sep; 260(3):857-65. PubMed ID: 21771954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.
    Sah RG; Sharma U; Parshad R; Seenu V; Mathur SR; Jagannathan NR
    Magn Reson Med; 2012 Oct; 68(4):1039-47. PubMed ID: 22213087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.